Oragenics Inc (OGEN)
1.08
0.00 (0.00%)
USD |
NYAM |
Apr 17, 16:00
1.08
0.00 (0.00%)
Pre-Market: 08:26
Oragenics Cash from Investing (TTM): -0.9363M for Dec. 31, 2023
Cash from Investing (TTM) Chart
Historical Cash from Investing (TTM) Data
Date | Value |
---|---|
December 31, 2023 | -0.9363M |
September 30, 2023 | 0.0603M |
June 30, 2023 | -0.0405M |
March 31, 2023 | -0.0405M |
December 31, 2022 | -0.1155M |
September 30, 2022 | -0.1318M |
June 30, 2022 | -0.1189M |
March 31, 2022 | |
December 31, 2021 | |
September 30, 2021 | |
June 30, 2021 | |
March 31, 2021 | |
December 31, 2020 | |
September 30, 2020 | |
June 30, 2020 |
Date | Value |
---|---|
March 31, 2020 | |
December 31, 2019 | |
September 30, 2019 | |
June 30, 2019 | |
March 31, 2019 | |
December 31, 2018 | |
September 30, 2018 | |
June 30, 2018 | |
March 31, 2018 | |
December 31, 2017 | |
September 30, 2017 | |
June 30, 2017 | |
March 31, 2017 | |
December 31, 2016 | 1.675M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (TTM) Range, Past 5 Years
-0.9363M
Minimum
Dec 2023
0.0603M
Maximum
Sep 2023
-0.189M
Average
-0.1155M
Median
Dec 2022
Cash from Investing (TTM) Benchmarks
Palatin Technologies Inc | 9.293M |
Inogen Inc | -59.32M |
Ampio Pharmaceuticals Inc | -- |
Actinium Pharmaceuticals Inc | -0.153M |
MAIA Biotechnology Inc | -- |